{"url":"https://lda.senate.gov/api/v1/filings/bef2f473-aaef-40c4-b471-e99e204e62f1/","filing_uuid":"bef2f473-aaef-40c4-b471-e99e204e62f1","filing_type":"RR","filing_type_display":"Registration","filing_year":2024,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/bef2f473-aaef-40c4-b471-e99e204e62f1/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Brian Pomper","dt_posted":"2024-04-26T17:02:01-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2001 K St NW","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":682,"url":"https://lda.senate.gov/api/v1/registrants/682/","house_registrant_id":31784,"name":"AKIN GUMP STRAUSS HAUER & FELD","description":"Law firm","address_1":"2001 K St NW","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRIAN POMPER","contact_telephone":"+1 202-887-4000","dt_updated":"2026-01-30T20:42:28.553875-05:00"},"client":{"id":59971,"url":"https://lda.senate.gov/api/v1/clients/59971/","client_id":59971,"name":"ALKEUS PHARMACEUTICALS, INC.","general_description":"Pharmaceutical company focused on degenerative eye diseases.","client_government_entity":null,"client_self_select":false,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2024-04-03"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to the development of rare disease therapies.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":68831,"prefix":null,"prefix_display":null,"first_name":"SEAN","nickname":null,"middle_name":null,"last_name":"FEELY","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":104715,"prefix":null,"prefix_display":null,"first_name":"ANNA","nickname":null,"middle_name":null,"last_name":"ABRAM","suffix":null,"suffix_display":null},"covered_position":"Dpty Comm, Pol, Leg, Intnl Affrs, FDA, Mar19Jan21; Mar17Mar19; Spcl Asst HHS, Jan21Mar17; Dec09Jan21; Hlth Dirctr, Sen Burr, Sen Hlth, L&P Comm, Apr09Dec09; Stff Mbr, Sen VA Comm, Feb09Apr09; AsstDrctr, WH Jan0709; LA, LC, SA, SenSantorum, May03Dec06","new":true},{"lobbyist":{"id":145964,"prefix":null,"prefix_display":null,"first_name":"MIA","nickname":null,"middle_name":null,"last_name":"HECK","suffix":null,"suffix_display":null},"covered_position":"Confidential Asst. to Asst. Sec Pub. Affairs, ASPA, HHS (9/02 - 3/04); Dir. Special Proj., IOS, HHS (1/05 - 2/06); Snr Adv. to Administrator, CMS, HHS (10/17 - 1/18); Snr Adv., IEA, HHS (1/18 - 6/19); Dir. External Affairs, OASH, HSS (6/19-1/21)","new":true},{"lobbyist":{"id":70247,"prefix":null,"prefix_display":null,"first_name":"VIRGIL","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":"Policy Fellow, Rep. Edolphus Towns, Aug06 - Feb07; Prof Staff Mber, Commit on Eng and Com, Feb 07 - Jan 11; Health Policy Advisor, Rep. John D. Dingell, Jan 09 - Jan 11; CoS, Rep. Cedric Richmond, Jan 11 - Mar 19","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}